Analysis for META
$736.72
-0.82
(-0.11%)
- 📈 Growth — 20/30
- 💰 Profitability — 19/20
- 🏦 Financial Health — 18/20
- 💵 Valuation — 15/20
- ⚠️ Risk — 6/10
Overall Score: 76/100
Summary:
📈 Growth & Financial Trajectory\nOver 8 quarters, Revenues rose from about $40.6B (2024 Q3) to about $60.8B (2026 Q2), a cumulative increase of roughly $20.2B (~49-50%). The trajectory is largely upward despite quarterly volatility: 2025 Q1 and Q3 show dips, while late 2025 into 2026 Q2 deliver a strong upturn. Net Income remained roughly flat, edging from about $15.7B to $15.8B with a notable trough in 2025 Q3. This yields a scenario of robust top-line expansion with earnings stability. Gross margin stayed high, around 81-83%, translating into solid operating leverage as revenue grows.\n\n### 💰 Margins & Cash Flow\n- Gross Margin: ~81-83% across quarters.\n- Operating Margin: mid-30s to low-40s percent, supported by strong operating income (e.g., 17-22B per quarter).\n- Cash flows: Net cash from operating activities generally positive, with late-2025 quarters showing roughly $29-36B; investing outflows offset, leading to modest free cash flow in some periods. Overall, liquidity supported by healthy cash generation.\n\n### 🛡️ Balance Sheet & Liquidity\n- Assets: latest around $450B; Equity around $261B; Liabilities around $189B; Long-term debt about $83.7B. This yields a solid balance sheet with large equity cushion and manageable leverage. Current assets about $125B and current liabilities about $56B indicate liquidity headroom.\n\n### ⚠️ Key Drivers & Risks\n* Drivers: AI/Data Center optimization, strong ad demand across META platforms.\n* Risks: Ad market cyclicality and regulatory/regulatory scrutiny; valuation sensitivity to ad revenue and platform policy changes.
📊 Key Financial Fundamentals
Valuation Multiples
Market Cap
$1,722.73B
P/E Ratio
25.30
Forward P/E
15.89
P/S Ratio
7.55
P/B Ratio
5.47
EV / EBITDA
16.33
Profitability & Returns
Gross Margin
81.75%
Operating Margin
38.08%
Net Margin
29.84%
ROE
29.73%
ROIC
23.74%
Financial Health & Liquidity
Current Ratio
2.23
Quick Ratio
2.00
Financial Scale & Cash Flow
Revenue
$228.25B
Net Income
$68.11B
FCF Yield
2.38%
Free Cash Flow
$40.98B
Total Debt To Equity
0.32